Sachin Wani
Concepts (637)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Barrett Esophagus | 112 | 2026 | 166 | 35.220 |
Why?
| | Esophageal Neoplasms | 86 | 2026 | 344 | 24.600 |
Why?
| | Adenocarcinoma | 71 | 2026 | 911 | 13.410 |
Why?
| | Esophagoscopy | 57 | 2026 | 220 | 11.590 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 44 | 2025 | 214 | 10.210 |
Why?
| | Gastroenterology | 31 | 2026 | 186 | 9.270 |
Why?
| | Endosonography | 38 | 2024 | 155 | 9.070 |
Why?
| | Precancerous Conditions | 30 | 2025 | 165 | 8.360 |
Why?
| | Endoscopy, Gastrointestinal | 43 | 2026 | 233 | 7.980 |
Why?
| | Endoscopy, Digestive System | 25 | 2023 | 139 | 6.890 |
Why?
| | Quality Indicators, Health Care | 19 | 2024 | 311 | 6.180 |
Why?
| | Colonoscopy | 33 | 2025 | 254 | 6.170 |
Why?
| | Colonic Polyps | 22 | 2025 | 83 | 5.690 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 20 | 2024 | 58 | 5.060 |
Why?
| | Gastroesophageal Reflux | 19 | 2023 | 244 | 4.420 |
Why?
| | Clinical Competence | 29 | 2026 | 1235 | 4.390 |
Why?
| | Esophagus | 22 | 2025 | 269 | 4.050 |
Why?
| | Pancreatic Neoplasms | 23 | 2024 | 924 | 3.170 |
Why?
| | Learning Curve | 13 | 2024 | 71 | 3.140 |
Why?
| | Endoscopic Mucosal Resection | 11 | 2024 | 31 | 2.860 |
Why?
| | Pancreatitis | 16 | 2025 | 136 | 2.770 |
Why?
| | Adenoma | 17 | 2023 | 221 | 2.750 |
Why?
| | Population Surveillance | 12 | 2024 | 488 | 2.710 |
Why?
| | Gastrointestinal Diseases | 9 | 2022 | 211 | 2.660 |
Why?
| | Humans | 307 | 2026 | 143560 | 2.550 |
Why?
| | Endoscopy | 15 | 2021 | 329 | 2.360 |
Why?
| | Biopsy | 24 | 2025 | 1083 | 2.260 |
Why?
| | Early Detection of Cancer | 15 | 2025 | 445 | 2.050 |
Why?
| | Cholangitis | 6 | 2024 | 24 | 1.900 |
Why?
| | Stents | 17 | 2025 | 543 | 1.850 |
Why?
| | Colorectal Neoplasms | 14 | 2023 | 833 | 1.820 |
Why?
| | Pancreatic Cyst | 4 | 2020 | 50 | 1.810 |
Why?
| | Fellowships and Scholarships | 6 | 2026 | 333 | 1.690 |
Why?
| | Prospective Studies | 47 | 2026 | 7900 | 1.650 |
Why?
| | Watchful Waiting | 8 | 2021 | 88 | 1.620 |
Why?
| | Guideline Adherence | 5 | 2021 | 574 | 1.610 |
Why?
| | Catheter Ablation | 8 | 2022 | 341 | 1.590 |
Why?
| | Bile Duct Neoplasms | 5 | 2023 | 121 | 1.580 |
Why?
| | Narrow Band Imaging | 8 | 2022 | 14 | 1.580 |
Why?
| | Societies, Medical | 10 | 2026 | 873 | 1.580 |
Why?
| | Disease Progression | 22 | 2025 | 2856 | 1.540 |
Why?
| | Sphincterotomy, Endoscopic | 10 | 2024 | 29 | 1.470 |
Why?
| | Pancreatic Diseases | 10 | 2020 | 67 | 1.370 |
Why?
| | Middle Aged | 101 | 2026 | 35343 | 1.360 |
Why?
| | Aged | 82 | 2026 | 25322 | 1.360 |
Why?
| | Hyperplasia | 8 | 2024 | 174 | 1.330 |
Why?
| | Education, Medical, Graduate | 8 | 2024 | 541 | 1.320 |
Why?
| | Neoplasm Recurrence, Local | 7 | 2026 | 1095 | 1.250 |
Why?
| | Fiducial Markers | 2 | 2019 | 9 | 1.210 |
Why?
| | Pancreas | 10 | 2024 | 333 | 1.170 |
Why?
| | Male | 116 | 2026 | 71501 | 1.170 |
Why?
| | Gastrointestinal Neoplasms | 3 | 2024 | 75 | 1.140 |
Why?
| | Registries | 9 | 2025 | 2238 | 1.110 |
Why?
| | Female | 113 | 2026 | 77252 | 1.090 |
Why?
| | United States | 41 | 2026 | 15554 | 1.090 |
Why?
| | Incidence | 21 | 2026 | 2844 | 1.030 |
Why?
| | Needles | 5 | 2024 | 63 | 1.030 |
Why?
| | Ampulla of Vater | 4 | 2023 | 36 | 1.030 |
Why?
| | Esophageal Achalasia | 4 | 2026 | 29 | 1.010 |
Why?
| | Choledocholithiasis | 3 | 2023 | 19 | 1.000 |
Why?
| | Ablation Techniques | 4 | 2024 | 36 | 1.000 |
Why?
| | Benchmarking | 4 | 2022 | 183 | 0.990 |
Why?
| | Esophagitis, Peptic | 3 | 2023 | 17 | 0.970 |
Why?
| | Esophagectomy | 7 | 2023 | 138 | 0.970 |
Why?
| | Catheterization | 9 | 2024 | 185 | 0.960 |
Why?
| | Biopsy, Fine-Needle | 4 | 2017 | 70 | 0.960 |
Why?
| | Rectum | 2 | 2019 | 187 | 0.940 |
Why?
| | Intestinal Polyps | 2 | 2016 | 15 | 0.940 |
Why?
| | Practice Guidelines as Topic | 12 | 2025 | 1557 | 0.920 |
Why?
| | Digestive System Diseases | 3 | 2015 | 27 | 0.910 |
Why?
| | Observer Variation | 14 | 2025 | 361 | 0.910 |
Why?
| | Gastrointestinal Hemorrhage | 5 | 2024 | 137 | 0.890 |
Why?
| | Aptitude | 2 | 2015 | 37 | 0.880 |
Why?
| | Biliary Tract Diseases | 5 | 2020 | 33 | 0.880 |
Why?
| | Cholestasis | 4 | 2023 | 217 | 0.880 |
Why?
| | Laryngopharyngeal Reflux | 2 | 2021 | 16 | 0.870 |
Why?
| | Pepsin A | 2 | 2021 | 18 | 0.870 |
Why?
| | Incidental Findings | 1 | 2025 | 81 | 0.860 |
Why?
| | Self-Assessment | 1 | 2025 | 75 | 0.860 |
Why?
| | Self Expandable Metallic Stents | 2 | 2021 | 17 | 0.850 |
Why?
| | Pancreatic Ducts | 7 | 2024 | 80 | 0.850 |
Why?
| | Practice Patterns, Physicians' | 6 | 2021 | 1362 | 0.840 |
Why?
| | Margins of Excision | 1 | 2024 | 48 | 0.840 |
Why?
| | Lymph Nodes | 4 | 2015 | 499 | 0.820 |
Why?
| | Taurine | 1 | 2023 | 40 | 0.810 |
Why?
| | Treatment Outcome | 30 | 2026 | 11365 | 0.810 |
Why?
| | Colonic Pseudo-Obstruction | 2 | 2020 | 4 | 0.800 |
Why?
| | Neoplasm Staging | 8 | 2024 | 1416 | 0.790 |
Why?
| | Intestinal Volvulus | 2 | 2020 | 23 | 0.770 |
Why?
| | Time-to-Treatment | 1 | 2024 | 228 | 0.760 |
Why?
| | Drainage | 8 | 2024 | 182 | 0.750 |
Why?
| | Stomach Diseases | 2 | 2014 | 20 | 0.730 |
Why?
| | Disease Management | 3 | 2021 | 646 | 0.730 |
Why?
| | Rectal Diseases | 2 | 2019 | 24 | 0.720 |
Why?
| | Postoperative Complications | 6 | 2025 | 2887 | 0.710 |
Why?
| | Endoscopes | 2 | 2021 | 17 | 0.710 |
Why?
| | Teaching Rounds | 1 | 2022 | 73 | 0.700 |
Why?
| | Deglutition Disorders | 2 | 2021 | 151 | 0.690 |
Why?
| | Esophageal Sphincter, Lower | 2 | 2021 | 14 | 0.680 |
Why?
| | Equipment Reuse | 1 | 2021 | 18 | 0.670 |
Why?
| | Esophageal Diseases | 2 | 2014 | 29 | 0.670 |
Why?
| | Dilatation | 3 | 2019 | 71 | 0.670 |
Why?
| | Argon Plasma Coagulation | 1 | 2020 | 6 | 0.660 |
Why?
| | Referral and Consultation | 4 | 2024 | 828 | 0.660 |
Why?
| | Hemostasis, Endoscopic | 1 | 2020 | 2 | 0.660 |
Why?
| | Retrospective Studies | 37 | 2026 | 16740 | 0.650 |
Why?
| | Sensitivity and Specificity | 19 | 2023 | 1984 | 0.650 |
Why?
| | Pancreatectomy | 3 | 2021 | 267 | 0.650 |
Why?
| | Biomarkers, Tumor | 2 | 2025 | 1282 | 0.650 |
Why?
| | Gastrointestinal Stromal Tumors | 2 | 2017 | 39 | 0.650 |
Why?
| | Competency-Based Education | 2 | 2024 | 83 | 0.640 |
Why?
| | Delphi Technique | 6 | 2024 | 326 | 0.640 |
Why?
| | Heller Myotomy | 1 | 2019 | 2 | 0.640 |
Why?
| | Time Factors | 15 | 2026 | 7032 | 0.630 |
Why?
| | Acetylcholine Release Inhibitors | 1 | 2019 | 4 | 0.630 |
Why?
| | Cohort Studies | 12 | 2025 | 5891 | 0.630 |
Why?
| | Sigmoid Diseases | 1 | 2019 | 14 | 0.630 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 28 | 0.620 |
Why?
| | Adult | 50 | 2026 | 40012 | 0.620 |
Why?
| | SEER Program | 4 | 2020 | 220 | 0.620 |
Why?
| | Bile Ducts | 3 | 2014 | 67 | 0.620 |
Why?
| | Cholinesterase Inhibitors | 1 | 2019 | 45 | 0.620 |
Why?
| | Proctoscopy | 1 | 2019 | 5 | 0.610 |
Why?
| | Predictive Value of Tests | 18 | 2025 | 2086 | 0.610 |
Why?
| | Conflict of Interest | 1 | 2020 | 48 | 0.610 |
Why?
| | Carcinoma | 3 | 2021 | 230 | 0.610 |
Why?
| | Medical Overuse | 1 | 2019 | 29 | 0.600 |
Why?
| | Conservative Treatment | 1 | 2019 | 41 | 0.600 |
Why?
| | Risk Factors | 23 | 2025 | 10644 | 0.600 |
Why?
| | Botulinum Toxins | 1 | 2019 | 46 | 0.600 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2019 | 38 | 0.600 |
Why?
| | Quality of Health Care | 2 | 2021 | 650 | 0.590 |
Why?
| | Consensus | 6 | 2026 | 550 | 0.590 |
Why?
| | Decompression, Surgical | 1 | 2019 | 116 | 0.590 |
Why?
| | Racism | 1 | 2021 | 147 | 0.580 |
Why?
| | Myotomy | 3 | 2026 | 16 | 0.570 |
Why?
| | Colonic Neoplasms | 7 | 2022 | 259 | 0.570 |
Why?
| | Acute Disease | 8 | 2024 | 1015 | 0.570 |
Why?
| | Aged, 80 and over | 23 | 2025 | 8072 | 0.560 |
Why?
| | Stomach Neoplasms | 4 | 2024 | 118 | 0.560 |
Why?
| | Family Health | 1 | 2019 | 197 | 0.560 |
Why?
| | Intestinal Perforation | 2 | 2016 | 46 | 0.550 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 173 | 0.550 |
Why?
| | Radiation Injuries | 1 | 2019 | 149 | 0.550 |
Why?
| | Prosthesis Implantation | 1 | 2019 | 156 | 0.540 |
Why?
| | Cytological Techniques | 1 | 2017 | 28 | 0.530 |
Why?
| | Risk Assessment | 11 | 2025 | 3577 | 0.520 |
Why?
| | Evidence-Based Medicine | 7 | 2025 | 724 | 0.510 |
Why?
| | Quality Assurance, Health Care | 1 | 2019 | 322 | 0.510 |
Why?
| | Cathartics | 1 | 2016 | 15 | 0.500 |
Why?
| | Metaplasia | 10 | 2023 | 58 | 0.500 |
Why?
| | Diagnostic Tests, Routine | 1 | 2017 | 110 | 0.500 |
Why?
| | Documentation | 2 | 2023 | 194 | 0.500 |
Why?
| | Carcinoembryonic Antigen | 2 | 2018 | 37 | 0.490 |
Why?
| | Diarrhea | 3 | 2019 | 183 | 0.490 |
Why?
| | Osteitis Deformans | 3 | 2023 | 8 | 0.480 |
Why?
| | Hospitals | 1 | 2021 | 691 | 0.480 |
Why?
| | Specimen Handling | 1 | 2017 | 181 | 0.480 |
Why?
| | Indomethacin | 3 | 2025 | 81 | 0.480 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 27 | 0.470 |
Why?
| | Adenomatous Polyps | 1 | 2015 | 10 | 0.470 |
Why?
| | Natural Orifice Endoscopic Surgery | 4 | 2026 | 37 | 0.470 |
Why?
| | Liver Neoplasms | 4 | 2024 | 758 | 0.470 |
Why?
| | Cystadenoma, Mucinous | 1 | 2015 | 10 | 0.460 |
Why?
| | Cystadenocarcinoma, Mucinous | 1 | 2015 | 11 | 0.460 |
Why?
| | Pathology, Clinical | 1 | 2015 | 29 | 0.460 |
Why?
| | Hypnotics and Sedatives | 2 | 2020 | 217 | 0.460 |
Why?
| | Carcinoma, Squamous Cell | 4 | 2014 | 647 | 0.460 |
Why?
| | Jaundice, Obstructive | 1 | 2014 | 3 | 0.450 |
Why?
| | Quality Improvement | 2 | 2021 | 1263 | 0.450 |
Why?
| | Duodenal Diseases | 1 | 2014 | 8 | 0.450 |
Why?
| | Aftercare | 4 | 2023 | 218 | 0.440 |
Why?
| | Pancreaticoduodenectomy | 1 | 2016 | 129 | 0.440 |
Why?
| | Ultrasonography, Interventional | 2 | 2019 | 158 | 0.440 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 32 | 0.430 |
Why?
| | Mucous Membrane | 9 | 2015 | 127 | 0.430 |
Why?
| | Duodenum | 1 | 2014 | 77 | 0.430 |
Why?
| | Colectomy | 1 | 2015 | 107 | 0.420 |
Why?
| | Neoplasms | 3 | 2020 | 2804 | 0.420 |
Why?
| | Advisory Committees | 5 | 2014 | 215 | 0.420 |
Why?
| | Cholecystectomy | 3 | 2019 | 58 | 0.420 |
Why?
| | Curriculum | 2 | 2024 | 1047 | 0.410 |
Why?
| | Recurrence | 4 | 2024 | 1114 | 0.410 |
Why?
| | Delivery of Health Care | 1 | 2021 | 954 | 0.410 |
Why?
| | Hemorrhage | 4 | 2020 | 804 | 0.410 |
Why?
| | Intestinal Mucosa | 4 | 2015 | 664 | 0.410 |
Why?
| | Multimodal Imaging | 1 | 2014 | 120 | 0.400 |
Why?
| | Logistic Models | 9 | 2025 | 2107 | 0.400 |
Why?
| | Precision Medicine | 1 | 2017 | 444 | 0.400 |
Why?
| | Internship and Residency | 3 | 2021 | 1250 | 0.390 |
Why?
| | Polyps | 1 | 2013 | 13 | 0.390 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2012 | 9 | 0.390 |
Why?
| | Education, Medical, Continuing | 3 | 2022 | 128 | 0.390 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2013 | 61 | 0.390 |
Why?
| | Tomography, X-Ray Computed | 6 | 2020 | 2779 | 0.390 |
Why?
| | Positron-Emission Tomography | 1 | 2014 | 310 | 0.390 |
Why?
| | Educational Measurement | 4 | 2025 | 324 | 0.380 |
Why?
| | Reproducibility of Results | 16 | 2023 | 3380 | 0.370 |
Why?
| | Gastroenterologists | 2 | 2022 | 17 | 0.370 |
Why?
| | Cholecystitis | 3 | 2024 | 23 | 0.370 |
Why?
| | Enteral Nutrition | 3 | 2021 | 220 | 0.370 |
Why?
| | Mass Screening | 6 | 2025 | 1334 | 0.370 |
Why?
| | Multivariate Analysis | 7 | 2021 | 1510 | 0.360 |
Why?
| | Health Care Costs | 1 | 2015 | 423 | 0.360 |
Why?
| | Pancreatitis, Chronic | 3 | 2024 | 61 | 0.360 |
Why?
| | Cholangiocarcinoma | 1 | 2013 | 100 | 0.360 |
Why?
| | Pandemics | 6 | 2023 | 1668 | 0.360 |
Why?
| | Manometry | 3 | 2021 | 97 | 0.350 |
Why?
| | Follow-Up Studies | 11 | 2026 | 5308 | 0.350 |
Why?
| | Neuroendocrine Tumors | 3 | 2018 | 112 | 0.340 |
Why?
| | Laparoscopy | 1 | 2015 | 474 | 0.340 |
Why?
| | Propofol | 1 | 2011 | 89 | 0.340 |
Why?
| | Pneumonia, Viral | 3 | 2020 | 378 | 0.340 |
Why?
| | Sex Factors | 5 | 2021 | 2092 | 0.330 |
Why?
| | Coronavirus Infections | 3 | 2020 | 373 | 0.330 |
Why?
| | Video Recording | 7 | 2019 | 207 | 0.330 |
Why?
| | Hypotension | 1 | 2011 | 126 | 0.330 |
Why?
| | Pathology, Surgical | 1 | 2010 | 8 | 0.330 |
Why?
| | Duodenal Neoplasms | 2 | 2023 | 25 | 0.320 |
Why?
| | Diagnostic Techniques, Digestive System | 2 | 2019 | 12 | 0.310 |
Why?
| | Education, Medical | 1 | 2013 | 276 | 0.310 |
Why?
| | Irritable Bowel Syndrome | 2 | 2019 | 29 | 0.300 |
Why?
| | Wandering Spleen | 1 | 2008 | 2 | 0.300 |
Why?
| | Odds Ratio | 4 | 2018 | 1060 | 0.300 |
Why?
| | Hernia, Hiatal | 4 | 2021 | 40 | 0.300 |
Why?
| | Informed Consent | 3 | 2022 | 195 | 0.290 |
Why?
| | Histocytochemistry | 4 | 2013 | 80 | 0.290 |
Why?
| | Computer-Assisted Instruction | 4 | 2024 | 69 | 0.290 |
Why?
| | Survival Rate | 3 | 2021 | 2003 | 0.280 |
Why?
| | Image Enhancement | 6 | 2018 | 194 | 0.280 |
Why?
| | Tertiary Care Centers | 4 | 2016 | 182 | 0.270 |
Why?
| | Surgeons | 2 | 2022 | 336 | 0.270 |
Why?
| | Proportional Hazards Models | 2 | 2026 | 1292 | 0.270 |
Why?
| | Decision Trees | 2 | 2019 | 81 | 0.270 |
Why?
| | Microscopy, Confocal | 5 | 2020 | 326 | 0.270 |
Why?
| | Proton Pump Inhibitors | 3 | 2022 | 111 | 0.260 |
Why?
| | Obesity | 5 | 2025 | 3042 | 0.260 |
Why?
| | Constriction, Pathologic | 6 | 2023 | 246 | 0.260 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 3 | 2025 | 352 | 0.260 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2026 | 361 | 0.260 |
Why?
| | Liver Transplantation | 1 | 2014 | 814 | 0.260 |
Why?
| | Malignant Catarrh | 1 | 2006 | 1 | 0.260 |
Why?
| | Goats | 1 | 2006 | 24 | 0.260 |
Why?
| | Sphincter of Oddi | 3 | 2024 | 5 | 0.250 |
Why?
| | Fluid Therapy | 2 | 2018 | 143 | 0.250 |
Why?
| | Herpesviridae | 1 | 2006 | 22 | 0.250 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2024 | 365 | 0.250 |
Why?
| | Osteoclasts | 4 | 2023 | 56 | 0.250 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 2 | 2019 | 25 | 0.250 |
Why?
| | Age Factors | 5 | 2020 | 3328 | 0.250 |
Why?
| | Picolinic Acids | 1 | 2006 | 8 | 0.240 |
Why?
| | Pyloromyotomy | 1 | 2026 | 3 | 0.240 |
Why?
| | Kidney Tubular Necrosis, Acute | 1 | 2006 | 26 | 0.240 |
Why?
| | Carrier State | 1 | 2006 | 75 | 0.240 |
Why?
| | Prevalence | 7 | 2023 | 2830 | 0.240 |
Why?
| | Genetic Predisposition to Disease | 4 | 2022 | 2417 | 0.230 |
Why?
| | Lithotripsy | 3 | 2024 | 49 | 0.230 |
Why?
| | Finland | 1 | 2025 | 81 | 0.230 |
Why?
| | Pancreatic Pseudocyst | 3 | 2024 | 17 | 0.230 |
Why?
| | Decision Support Techniques | 3 | 2019 | 438 | 0.230 |
Why?
| | Sweden | 1 | 2025 | 109 | 0.230 |
Why?
| | Thinness | 1 | 2025 | 98 | 0.230 |
Why?
| | Singapore | 1 | 2025 | 23 | 0.230 |
Why?
| | Sphincter of Oddi Dysfunction | 1 | 2024 | 1 | 0.230 |
Why?
| | Diagnosis, Differential | 6 | 2019 | 1504 | 0.220 |
Why?
| | Cattle Diseases | 1 | 2005 | 26 | 0.220 |
Why?
| | Feasibility Studies | 6 | 2024 | 1051 | 0.220 |
Why?
| | Heartburn | 2 | 2021 | 12 | 0.220 |
Why?
| | DNA, Viral | 1 | 2006 | 366 | 0.220 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2017 | 308 | 0.210 |
Why?
| | Metabolic Diseases | 1 | 2025 | 116 | 0.210 |
Why?
| | Escherichia coli Infections | 1 | 2005 | 119 | 0.210 |
Why?
| | Hypoxia | 1 | 2011 | 1177 | 0.210 |
Why?
| | Program Evaluation | 2 | 2020 | 937 | 0.210 |
Why?
| | Patient Acceptance of Health Care | 2 | 2026 | 884 | 0.210 |
Why?
| | Case-Control Studies | 7 | 2025 | 3625 | 0.210 |
Why?
| | Bile Duct Diseases | 2 | 2014 | 13 | 0.210 |
Why?
| | Sheep | 1 | 2006 | 885 | 0.200 |
Why?
| | Biomarkers | 6 | 2025 | 4241 | 0.200 |
Why?
| | Common Bile Duct Neoplasms | 1 | 2023 | 24 | 0.200 |
Why?
| | G-Protein-Coupled Receptor Kinase 3 | 1 | 2023 | 2 | 0.200 |
Why?
| | Postoperative Hemorrhage | 1 | 2024 | 90 | 0.200 |
Why?
| | Ergonomics | 1 | 2023 | 24 | 0.200 |
Why?
| | Pancreatitis, Acute Necrotizing | 1 | 2023 | 15 | 0.200 |
Why?
| | Kaplan-Meier Estimate | 3 | 2020 | 921 | 0.200 |
Why?
| | Cytodiagnosis | 2 | 2020 | 31 | 0.200 |
Why?
| | Cholelithiasis | 1 | 2023 | 37 | 0.200 |
Why?
| | Microsurgery | 1 | 2023 | 78 | 0.190 |
Why?
| | Cause of Death | 1 | 2025 | 459 | 0.190 |
Why?
| | Carcinoid Tumor | 1 | 2022 | 22 | 0.190 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 100 | 0.190 |
Why?
| | Appendiceal Neoplasms | 1 | 2022 | 28 | 0.190 |
Why?
| | Bone Resorption | 1 | 2023 | 85 | 0.190 |
Why?
| | Forecasting | 1 | 2024 | 384 | 0.190 |
Why?
| | Fluorouracil | 1 | 2023 | 210 | 0.190 |
Why?
| | Bone Diseases, Metabolic | 1 | 2023 | 64 | 0.190 |
Why?
| | Hospitalization | 4 | 2026 | 2313 | 0.190 |
Why?
| | Biomedical Research | 2 | 2020 | 699 | 0.190 |
Why?
| | Medicare | 2 | 2021 | 811 | 0.190 |
Why?
| | Surgical Instruments | 3 | 2022 | 52 | 0.190 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 204 | 0.180 |
Why?
| | Drug Monitoring | 1 | 2026 | 396 | 0.180 |
Why?
| | Metabolome | 1 | 2025 | 374 | 0.180 |
Why?
| | Health Care Surveys | 3 | 2020 | 565 | 0.180 |
Why?
| | Diverticulum, Esophageal | 1 | 2021 | 4 | 0.180 |
Why?
| | Gastrectomy | 2 | 2023 | 143 | 0.180 |
Why?
| | Esophageal Sphincter, Upper | 1 | 2021 | 7 | 0.180 |
Why?
| | Weight Loss | 2 | 2021 | 812 | 0.180 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.180 |
Why?
| | Professional Practice Location | 2 | 2019 | 28 | 0.180 |
Why?
| | Biopsy, Needle | 2 | 2020 | 190 | 0.180 |
Why?
| | Dietary Supplements | 1 | 2006 | 587 | 0.170 |
Why?
| | Aspirin | 1 | 2025 | 398 | 0.170 |
Why?
| | Disease Outbreaks | 1 | 2005 | 430 | 0.170 |
Why?
| | Single-Blind Method | 5 | 2014 | 294 | 0.170 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2021 | 13 | 0.170 |
Why?
| | Trefoil Factor-3 | 1 | 2020 | 5 | 0.170 |
Why?
| | Internationality | 2 | 2020 | 158 | 0.170 |
Why?
| | Gastric Outlet Obstruction | 1 | 2020 | 12 | 0.170 |
Why?
| | Formative Feedback | 2 | 2024 | 29 | 0.170 |
Why?
| | Oral Submucous Fibrosis | 1 | 2020 | 2 | 0.170 |
Why?
| | Radiography, Abdominal | 2 | 2012 | 44 | 0.170 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 389 | 0.160 |
Why?
| | Digestive System Surgical Procedures | 1 | 2021 | 109 | 0.160 |
Why?
| | Midazolam | 1 | 2020 | 72 | 0.160 |
Why?
| | Stomach | 2 | 2012 | 117 | 0.160 |
Why?
| | Varicose Veins | 1 | 2020 | 16 | 0.160 |
Why?
| | Betacoronavirus | 2 | 2020 | 280 | 0.160 |
Why?
| | Equipment Contamination | 1 | 2021 | 71 | 0.160 |
Why?
| | Escherichia coli | 1 | 2005 | 834 | 0.160 |
Why?
| | Laparotomy | 2 | 2012 | 116 | 0.160 |
Why?
| | Esophageal and Gastric Varices | 1 | 2020 | 35 | 0.160 |
Why?
| | Cost-Benefit Analysis | 3 | 2015 | 621 | 0.160 |
Why?
| | United Arab Emirates | 1 | 2020 | 7 | 0.160 |
Why?
| | Emergencies | 1 | 2021 | 180 | 0.160 |
Why?
| | Morbidity | 1 | 2021 | 321 | 0.160 |
Why?
| | Cecum | 1 | 2019 | 33 | 0.160 |
Why?
| | Body Fluids | 1 | 2020 | 70 | 0.160 |
Why?
| | Colostomy | 1 | 2019 | 28 | 0.160 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2020 | 38 | 0.160 |
Why?
| | Neostigmine | 1 | 2019 | 21 | 0.160 |
Why?
| | Disease Transmission, Infectious | 1 | 2020 | 70 | 0.150 |
Why?
| | Survival Analysis | 2 | 2015 | 1332 | 0.150 |
Why?
| | Accreditation | 1 | 2020 | 95 | 0.150 |
Why?
| | Dissection | 2 | 2020 | 55 | 0.150 |
Why?
| | Perception | 1 | 2022 | 378 | 0.150 |
Why?
| | Mirizzi Syndrome | 1 | 2019 | 2 | 0.150 |
Why?
| | Saliva | 1 | 2021 | 247 | 0.150 |
Why?
| | Research Design | 2 | 2020 | 1123 | 0.150 |
Why?
| | Urinary Calculi | 1 | 2019 | 10 | 0.150 |
Why?
| | Injections, Intramuscular | 1 | 2019 | 143 | 0.150 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2024 | 1672 | 0.150 |
Why?
| | Disinfection | 1 | 2021 | 130 | 0.150 |
Why?
| | India | 3 | 2018 | 214 | 0.150 |
Why?
| | Ascites | 1 | 2019 | 49 | 0.150 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2020 | 317 | 0.150 |
Why?
| | ROC Curve | 4 | 2015 | 603 | 0.150 |
Why?
| | Anastomotic Leak | 1 | 2019 | 45 | 0.150 |
Why?
| | Propensity Score | 2 | 2025 | 350 | 0.150 |
Why?
| | Mastitis, Bovine | 1 | 2018 | 2 | 0.150 |
Why?
| | Feedback | 1 | 2019 | 180 | 0.150 |
Why?
| | Obesity, Morbid | 1 | 2023 | 278 | 0.150 |
Why?
| | Chronic Disease | 3 | 2019 | 1824 | 0.150 |
Why?
| | Esophageal Mucosa | 1 | 2018 | 22 | 0.140 |
Why?
| | Infection Control | 1 | 2020 | 173 | 0.140 |
Why?
| | Phage Therapy | 1 | 2018 | 17 | 0.140 |
Why?
| | Fluoroscopy | 1 | 2019 | 171 | 0.140 |
Why?
| | Plastics | 2 | 2018 | 48 | 0.140 |
Why?
| | Esophagogastric Junction | 3 | 2021 | 52 | 0.140 |
Why?
| | Gallstones | 1 | 2018 | 33 | 0.140 |
Why?
| | Colonoscopes | 3 | 2014 | 5 | 0.140 |
Why?
| | Quality-Adjusted Life Years | 2 | 2015 | 113 | 0.140 |
Why?
| | Clinical Protocols | 1 | 2019 | 279 | 0.140 |
Why?
| | Cystadenoma, Serous | 1 | 2018 | 18 | 0.140 |
Why?
| | Health Status Disparities | 1 | 2021 | 307 | 0.140 |
Why?
| | Markov Chains | 2 | 2015 | 126 | 0.140 |
Why?
| | Mortality | 1 | 2020 | 364 | 0.140 |
Why?
| | Aneurysm, False | 1 | 2018 | 45 | 0.130 |
Why?
| | Diagnostic Techniques and Procedures | 1 | 2017 | 21 | 0.130 |
Why?
| | Reference Standards | 1 | 2018 | 181 | 0.130 |
Why?
| | Cardia | 2 | 2007 | 2 | 0.130 |
Why?
| | Prognosis | 3 | 2017 | 4152 | 0.130 |
Why?
| | Medical Staff Privileges | 1 | 2017 | 5 | 0.130 |
Why?
| | Education | 1 | 2017 | 107 | 0.130 |
Why?
| | Anti-Bacterial Agents | 2 | 2018 | 1906 | 0.130 |
Why?
| | Optical Imaging | 2 | 2018 | 64 | 0.130 |
Why?
| | Cattle | 3 | 2018 | 990 | 0.130 |
Why?
| | Credentialing | 1 | 2017 | 21 | 0.130 |
Why?
| | MicroRNAs | 2 | 2015 | 698 | 0.130 |
Why?
| | Severity of Illness Index | 6 | 2021 | 2936 | 0.130 |
Why?
| | Bacteriophages | 1 | 2018 | 110 | 0.130 |
Why?
| | Palliative Care | 2 | 2021 | 852 | 0.130 |
Why?
| | Research | 1 | 2020 | 438 | 0.130 |
Why?
| | Iatrogenic Disease | 1 | 2017 | 76 | 0.120 |
Why?
| | Leiomyoma | 1 | 2017 | 58 | 0.120 |
Why?
| | Immunoassay | 1 | 2017 | 110 | 0.120 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2016 | 12 | 0.120 |
Why?
| | Quality of Life | 2 | 2024 | 3080 | 0.120 |
Why?
| | Patient Discharge | 1 | 2023 | 923 | 0.120 |
Why?
| | Artificial Intelligence | 1 | 2020 | 365 | 0.120 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 686 | 0.120 |
Why?
| | Chemoprevention | 2 | 2014 | 95 | 0.120 |
Why?
| | Analysis of Variance | 1 | 2018 | 1314 | 0.120 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2016 | 78 | 0.120 |
Why?
| | Bariatric Surgery | 1 | 2019 | 233 | 0.110 |
Why?
| | Global Health | 1 | 2018 | 387 | 0.110 |
Why?
| | Antibiotic Prophylaxis | 1 | 2016 | 128 | 0.110 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2015 | 22 | 0.110 |
Why?
| | Teaching | 1 | 2017 | 233 | 0.110 |
Why?
| | Physicians | 1 | 2024 | 940 | 0.110 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2015 | 59 | 0.110 |
Why?
| | Metals | 3 | 2023 | 142 | 0.110 |
Why?
| | Costs and Cost Analysis | 1 | 2015 | 220 | 0.110 |
Why?
| | Surveys and Questionnaires | 8 | 2024 | 6025 | 0.110 |
Why?
| | Intestinal Fistula | 1 | 2014 | 17 | 0.110 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2015 | 66 | 0.110 |
Why?
| | Cryosurgery | 1 | 2015 | 47 | 0.110 |
Why?
| | Administration, Rectal | 2 | 2024 | 13 | 0.110 |
Why?
| | Task Performance and Analysis | 1 | 2015 | 196 | 0.110 |
Why?
| | Colorectal Surgery | 1 | 2014 | 30 | 0.110 |
Why?
| | Body Mass Index | 4 | 2025 | 2430 | 0.110 |
Why?
| | Goblet Cells | 1 | 2013 | 22 | 0.100 |
Why?
| | Combined Modality Therapy | 2 | 2015 | 1252 | 0.100 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 397 | 0.100 |
Why?
| | Prosthesis Failure | 1 | 2014 | 125 | 0.100 |
Why?
| | Health Status | 1 | 2019 | 824 | 0.100 |
Why?
| | Suture Techniques | 1 | 2014 | 130 | 0.100 |
Why?
| | Bone Density | 1 | 2017 | 503 | 0.100 |
Why?
| | Patient Participation | 1 | 2017 | 434 | 0.100 |
Why?
| | Primary Health Care | 2 | 2022 | 1779 | 0.100 |
Why?
| | Animals, Newborn | 2 | 2006 | 882 | 0.100 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 40 | 0.100 |
Why?
| | Light | 2 | 2013 | 401 | 0.100 |
Why?
| | Jejunum | 1 | 2012 | 33 | 0.100 |
Why?
| | Polymerase Chain Reaction | 2 | 2006 | 1062 | 0.090 |
Why?
| | Equipment Design | 3 | 2021 | 533 | 0.090 |
Why?
| | Mediastinum | 1 | 2012 | 22 | 0.090 |
Why?
| | Feces | 2 | 2026 | 496 | 0.090 |
Why?
| | Peptides | 1 | 2017 | 976 | 0.090 |
Why?
| | Young Adult | 8 | 2025 | 13972 | 0.090 |
Why?
| | Decision Making | 3 | 2023 | 962 | 0.090 |
Why?
| | Anesthetics, Intravenous | 1 | 2011 | 73 | 0.090 |
Why?
| | Injections, Intravenous | 1 | 2011 | 203 | 0.090 |
Why?
| | Abdomen | 1 | 2012 | 140 | 0.090 |
Why?
| | Patient Selection | 1 | 2015 | 691 | 0.080 |
Why?
| | Guidelines as Topic | 1 | 2012 | 270 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2015 | 752 | 0.080 |
Why?
| | Adrenal Glands | 1 | 2011 | 79 | 0.080 |
Why?
| | Intestines | 1 | 2013 | 356 | 0.080 |
Why?
| | Esophagitis | 2 | 2007 | 67 | 0.080 |
Why?
| | Proteomics | 1 | 2017 | 1161 | 0.080 |
Why?
| | Esophageal pH Monitoring | 1 | 2009 | 24 | 0.080 |
Why?
| | Veterans | 1 | 2021 | 1545 | 0.080 |
Why?
| | Adolescent | 8 | 2025 | 22482 | 0.080 |
Why?
| | North America | 2 | 2020 | 308 | 0.080 |
Why?
| | Software | 1 | 2014 | 687 | 0.070 |
Why?
| | Gastric Acid | 1 | 2009 | 14 | 0.070 |
Why?
| | Antacids | 1 | 2009 | 16 | 0.070 |
Why?
| | Remission Induction | 1 | 2009 | 306 | 0.070 |
Why?
| | National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 2 | 2017 | 10 | 0.070 |
Why?
| | Hematoporphyrin Photoradiation | 1 | 2007 | 1 | 0.070 |
Why?
| | Colonography, Computed Tomographic | 1 | 2007 | 8 | 0.070 |
Why?
| | Patient Care Planning | 1 | 2009 | 161 | 0.070 |
Why?
| | Gastric Fundus | 1 | 2007 | 3 | 0.070 |
Why?
| | Capsule Endoscopy | 1 | 2007 | 18 | 0.070 |
Why?
| | Clinical Trials as Topic | 2 | 2015 | 1043 | 0.060 |
Why?
| | Algorithms | 3 | 2026 | 1813 | 0.060 |
Why?
| | Plasmapheresis | 1 | 2006 | 24 | 0.060 |
Why?
| | Gastritis | 1 | 2007 | 115 | 0.060 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2026 | 39 | 0.060 |
Why?
| | Overweight | 2 | 2025 | 598 | 0.060 |
Why?
| | CDX2 Transcription Factor | 1 | 2025 | 1 | 0.060 |
Why?
| | Dairying | 1 | 2005 | 11 | 0.060 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2007 | 277 | 0.060 |
Why?
| | Autonomic Nerve Block | 1 | 2024 | 10 | 0.060 |
Why?
| | Celiac Plexus | 1 | 2024 | 6 | 0.060 |
Why?
| | Hyperlipidemias | 1 | 2025 | 127 | 0.060 |
Why?
| | Animals | 6 | 2023 | 38010 | 0.050 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2025 | 77 | 0.050 |
Why?
| | Image-Guided Biopsy | 2 | 2015 | 42 | 0.050 |
Why?
| | DNA Primers | 1 | 2005 | 518 | 0.050 |
Why?
| | Virulence | 1 | 2005 | 275 | 0.050 |
Why?
| | Seasons | 1 | 2006 | 556 | 0.050 |
Why?
| | Glypicans | 1 | 2023 | 11 | 0.050 |
Why?
| | DNA, Bacterial | 1 | 2005 | 333 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2026 | 418 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2007 | 839 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 169 | 0.050 |
Why?
| | United Kingdom | 1 | 2023 | 334 | 0.050 |
Why?
| | Tumor Burden | 2 | 2015 | 319 | 0.050 |
Why?
| | Biological Products | 1 | 2026 | 246 | 0.050 |
Why?
| | Liver | 1 | 2011 | 1864 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 1 | 2006 | 482 | 0.050 |
Why?
| | Pain Measurement | 1 | 2024 | 558 | 0.050 |
Why?
| | Necrosis | 1 | 2023 | 247 | 0.050 |
Why?
| | Appendectomy | 1 | 2022 | 89 | 0.050 |
Why?
| | Metabolic Syndrome | 1 | 2025 | 354 | 0.040 |
Why?
| | B7-H1 Antigen | 1 | 2024 | 233 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2006 | 460 | 0.040 |
Why?
| | Technology | 1 | 2022 | 96 | 0.040 |
Why?
| | Colonic Diseases | 2 | 2014 | 36 | 0.040 |
Why?
| | Osteogenesis | 1 | 2023 | 204 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2024 | 347 | 0.040 |
Why?
| | Blood Transfusion | 1 | 2024 | 401 | 0.040 |
Why?
| | Induction Chemotherapy | 1 | 2021 | 84 | 0.040 |
Why?
| | Lifting | 1 | 2020 | 4 | 0.040 |
Why?
| | Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 5 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 169 | 0.040 |
Why?
| | Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 20 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5743 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 589 | 0.040 |
Why?
| | Cough | 1 | 2021 | 133 | 0.040 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 434 | 0.040 |
Why?
| | Granuloma | 1 | 2020 | 97 | 0.040 |
Why?
| | Personal Protective Equipment | 1 | 2020 | 56 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2017 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2021 | 133 | 0.040 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 234 | 0.040 |
Why?
| | Cross-Over Studies | 2 | 2012 | 583 | 0.040 |
Why?
| | Length of Stay | 1 | 2025 | 1279 | 0.040 |
Why?
| | Myoviridae | 1 | 2018 | 1 | 0.040 |
Why?
| | Podoviridae | 1 | 2018 | 1 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 589 | 0.040 |
Why?
| | Pilot Projects | 3 | 2011 | 1838 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 548 | 0.040 |
Why?
| | Rural Population | 1 | 2023 | 617 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2017 | 4182 | 0.040 |
Why?
| | Coloring Agents | 1 | 2018 | 96 | 0.040 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2018 | 156 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2020 | 285 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2018 | 334 | 0.030 |
Why?
| | Cyst Fluid | 1 | 2018 | 21 | 0.030 |
Why?
| | Neoadjuvant Therapy | 1 | 2021 | 438 | 0.030 |
Why?
| | Abdominal Pain | 1 | 2019 | 144 | 0.030 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 2018 | 52 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 875 | 0.030 |
Why?
| | Hospitals, University | 1 | 2018 | 176 | 0.030 |
Why?
| | Review Literature as Topic | 1 | 2017 | 49 | 0.030 |
Why?
| | User-Computer Interface | 1 | 2018 | 165 | 0.030 |
Why?
| | Communication | 1 | 2024 | 953 | 0.030 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 180 | 0.030 |
Why?
| | Granular Cell Tumor | 1 | 2017 | 9 | 0.030 |
Why?
| | Lipoma | 1 | 2017 | 17 | 0.030 |
Why?
| | Choristoma | 1 | 2017 | 21 | 0.030 |
Why?
| | Mice | 3 | 2023 | 18378 | 0.030 |
Why?
| | Cancer Pain | 1 | 2017 | 35 | 0.030 |
Why?
| | Choledochal Cyst | 1 | 2016 | 17 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 3006 | 0.030 |
Why?
| | Genetic Testing | 1 | 2020 | 474 | 0.030 |
Why?
| | Gastroscopes | 1 | 2016 | 3 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2025 | 2852 | 0.030 |
Why?
| | Diabetes Mellitus | 1 | 2025 | 1089 | 0.030 |
Why?
| | Duodenoscopes | 1 | 2016 | 7 | 0.030 |
Why?
| | Genome, Viral | 1 | 2018 | 224 | 0.030 |
Why?
| | Biliary Tract Neoplasms | 1 | 2016 | 30 | 0.030 |
Why?
| | Embolism, Air | 1 | 2016 | 14 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 462 | 0.030 |
Why?
| | Exons | 1 | 2017 | 359 | 0.030 |
Why?
| | Nerve Block | 1 | 2017 | 97 | 0.030 |
Why?
| | Cholangitis, Sclerosing | 1 | 2016 | 57 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1126 | 0.030 |
Why?
| | DNA Methylation | 1 | 2021 | 667 | 0.030 |
Why?
| | Viral Proteins | 1 | 2018 | 370 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2023 | 2542 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2023 | 3611 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 748 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11737 | 0.030 |
Why?
| | Bone and Bones | 1 | 2017 | 321 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2519 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2015 | 254 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 471 | 0.030 |
Why?
| | Equipment Failure | 1 | 2014 | 112 | 0.030 |
Why?
| | Child | 3 | 2021 | 22725 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2021 | 691 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 1163 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2015 | 404 | 0.030 |
Why?
| | Proteome | 1 | 2018 | 494 | 0.030 |
Why?
| | Pain | 1 | 2019 | 781 | 0.030 |
Why?
| | Pathology | 1 | 2013 | 21 | 0.030 |
Why?
| | Health Status Indicators | 1 | 2014 | 161 | 0.030 |
Why?
| | Community Health Centers | 1 | 2013 | 63 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2021 | 2020 | 0.020 |
Why?
| | Autoimmune Diseases | 1 | 2017 | 469 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2015 | 346 | 0.020 |
Why?
| | Color | 1 | 2013 | 81 | 0.020 |
Why?
| | Community Health Services | 1 | 2014 | 234 | 0.020 |
Why?
| | Phenotype | 1 | 2021 | 3211 | 0.020 |
Why?
| | Neoplasm Grading | 1 | 2013 | 312 | 0.020 |
Why?
| | Adenoma, Villous | 1 | 2012 | 2 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1465 | 0.020 |
Why?
| | Gastroscopy | 1 | 2011 | 18 | 0.020 |
Why?
| | Sentinel Surveillance | 1 | 2011 | 48 | 0.020 |
Why?
| | Digestive System Neoplasms | 1 | 2011 | 9 | 0.020 |
Why?
| | Base Sequence | 1 | 2015 | 2199 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2012 | 332 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2011 | 118 | 0.020 |
Why?
| | Risk | 1 | 2013 | 906 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2013 | 535 | 0.020 |
Why?
| | Life Style | 1 | 2013 | 483 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3109 | 0.020 |
Why?
| | Genetic Markers | 1 | 2011 | 345 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1505 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 4053 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 994 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 858 | 0.020 |
Why?
| | Motor Activity | 1 | 2013 | 721 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 556 | 0.020 |
Why?
| | Geography | 1 | 2008 | 202 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2015 | 1452 | 0.020 |
Why?
| | Diagnostic Equipment | 1 | 2007 | 5 | 0.020 |
Why?
| | Helicobacter Infections | 1 | 2007 | 29 | 0.020 |
Why?
| | Colorado | 1 | 2018 | 4658 | 0.020 |
Why?
| | Fraud | 1 | 2007 | 9 | 0.020 |
Why?
| | Helicobacter pylori | 1 | 2007 | 44 | 0.020 |
Why?
| | Selenium | 1 | 2007 | 49 | 0.020 |
Why?
| | Electrocoagulation | 1 | 2007 | 35 | 0.020 |
Why?
| | Gastric Mucosa | 1 | 2007 | 53 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2015 | 2177 | 0.020 |
Why?
| | Quality Control | 1 | 2007 | 160 | 0.020 |
Why?
| | Laser Coagulation | 1 | 2007 | 73 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1736 | 0.020 |
Why?
| | Risk Management | 1 | 2007 | 91 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2007 | 317 | 0.020 |
Why?
| | Capillaries | 1 | 2007 | 125 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 6043 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 772 | 0.010 |
Why?
| | Diagnostic Imaging | 1 | 2007 | 333 | 0.010 |
Why?
| | Health Policy | 1 | 2007 | 393 | 0.010 |
Why?
| | Monocytes | 1 | 2007 | 545 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9981 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2195 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2007 | 1324 | 0.010 |
Why?
| | Comorbidity | 1 | 2007 | 1678 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2621 | 0.010 |
Why?
| | Neutrophils | 1 | 2007 | 1134 | 0.010 |
Why?
| | Smoking | 1 | 2007 | 1580 | 0.010 |
Why?
| | Diet | 1 | 2007 | 1290 | 0.010 |
Why?
|
|
Wani's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|